Summary by Moomoo AI
180 Life Sciences Corp., a Delaware corporation, announced the filing of a PRE 14A preliminary proxy statement with the SEC, scheduling its 2024 annual meeting of stockholders for December 27, 2024. The meeting will be held virtually, with stockholders unable to attend physically. The Board of Directors extended an invitation to stockholders to attend and vote on several proposals, including the election of three Class II directors, amendments to the 2022 Omnibus Incentive Plan, executive compensation, and the issuance of common stock upon conversion of Series B Convertible Preferred Stock and exercise of warrants. The meeting will also cover the ratification of M&K CPAs, PLLC as the company's independent auditors for the fiscal year ending December 31, 2024. The proxy statement was first sent to stockholders on or about November 11, 2024, and includes instructions for voting online, by mail, fax, or telephone. The Board unanimously recommends voting for all proposed items.
